key: cord-0971321-btydphq0
authors: Nasserie, Tahmina; Hittle, Michael; Goodman, Steven N.
title: Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review
date: 2021-05-26
journal: JAMA Netw Open
DOI: 10.1001/jamanetworkopen.2021.11417
sha: 714dadbd992c72247af72523a4ade25a194c95c9
doc_id: 971321
cord_uid: btydphq0

IMPORTANCE: Infection with COVID-19 has been associated with long-term symptoms, but the frequency, variety, and severity of these complications are not well understood. Many published commentaries have proposed plans for pandemic control that are primarily based on mortality rates among older individuals without considering long-term morbidity among individuals of all ages. Reliable estimates of such morbidity are important for patient care, prognosis, and development of public health policy. OBJECTIVE: To conduct a systematic review of studies examining the frequency and variety of persistent symptoms after COVID-19 infection. EVIDENCE REVIEW: A search of PubMed and Web of Science was conducted to identify studies published from January 1, 2020, to March 11, 2021, that examined persistent symptoms after COVID-19 infection. Persistent symptoms were defined as those persisting for at least 60 days after diagnosis, symptom onset, or hospitalization or at least 30 days after recovery from the acute illness or hospital discharge. Search terms included COVID-19, SARS-CoV-2, coronavirus, 2019-nCoV, long-term, after recovery, long-haul, persistent, outcome, symptom, follow-up, and longitudinal. All English-language articles that presented primary data from cohort studies that reported the prevalence of persistent symptoms among individuals with SARS-CoV-2 infection and that had clearly defined and sufficient follow-up were included. Case reports, case series, and studies that described symptoms only at the time of infection and/or hospitalization were excluded. A structured framework was applied to appraise study quality. FINDINGS: A total of 1974 records were identified; of those, 1247 article titles and abstracts were screened. After removal of duplicates and exclusions, 92 full-text articles were assessed for eligibility; 47 studies were deemed eligible, and 45 studies reporting 84 clinical signs or symptoms were included in the systematic review. Of 9751 total participants, 5266 (54.0%) were male; 30 of 45 studies reported mean or median ages younger than 60 years. Among 16 studies, most of which comprised participants who were previously hospitalized, the median proportion of individuals experiencing at least 1 persistent symptom was 72.5% (interquartile range [IQR], 55.0%-80.0%). Individual symptoms occurring most frequently included shortness of breath or dyspnea (26 studies; median frequency, 36.0%; IQR, 27.6%-50.0%), fatigue or exhaustion (25 studies; median frequency, 40.0%; IQR, 31.0%-57.0%), and sleep disorders or insomnia (8 studies; median 29.4%, IQR, 24.4%-33.0%). There were wide variations in the design and quality of the studies, which had implications for interpretation and often limited direct comparability and combinability. Major design differences included patient populations, definitions of time zero (ie, the beginning of the follow-up interval), follow-up lengths, and outcome definitions, including definitions of illness severity. CONCLUSIONS AND RELEVANCE: This systematic review found that COVID-19 symptoms commonly persisted beyond the acute phase of infection, with implications for health-associated functioning and quality of life. Current studies of symptom persistence are highly heterogeneous, and future studies need longer follow-up, improved quality, and more standardized designs to reliably quantify risks.

Varied for each participant; based on date of examination mMRC Dyspnea Scale (dyspnea); PHQ-9 (depression); TSQ (trauma); GAD-7 (anxiety); 6-CIT (cognitive impairment); CT scans (organ functioning); 4MGS (gait speed); 1-minute Sit to Stand Test (mobility) Daher 9 Hospital discharge 6 weeks after discharge All participants followed for same amount of time PHQ-9 (depression); GAD-7 (anxiety); EQ-5D-5L (QOL); 6 minute walk test (mobility); blood sample (lab assessments); electrocardiography, CT scans (organ functioning)

de Graaf 10 Hospital discharge 6 weeks after hospital discharge All participants followed for the same amount of time CT scans (organ functioning); pulmonary function tests; GAD-7 (anxiety); PHQ-9 (depression); PCL_5 (PTSD); CFQ-25 (cognitive impairment); IQ-CODE-N (cognitive impairment among elderly patients); NYHA (dyspnea) 

Clinical characteristics and short term outcomes after recovery from COVID-19 in patients with and without diabetes in Bangladesh

Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort

Gemelli Against COVID-19 Post-Acute Care Study Group

Follow-up of adults with non-critical COVID-19 two months after symptoms' onset

Predictors of Health-Related Quality of Life and Influencing Factors for COVID-19 Patients, a Follow-Up at One Month. Front Psychiatry

Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak

Sixty-Day Outcomes Among Patients Hospitalized With COVID-19

Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia

Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae

Short-term outpatient follow-up of COVID-19 patients: A multidisciplinary approach

Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19

Frequent and Persistent Salivary Gland Ectasia and Oral Disease After COVID-19

Pulmonary function and radiological features in survivors of critical COVID-19: a 3-month prospective cohort

Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection

Severity of Anosmia as an Early Symptom of COVID-19 Infection May Predict Lasting Loss of Smell

lung function and CT findings three months after hospital admission for COVID-19

Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge

Cerebral Micro-Structural Changes in COVID-19 Patients -An MRI-based 3-month Follow-up Study

Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19

Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up

Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors

Post-acute COVID-19 Syndrome. Incidence and risk factors: a Mediterranean cohort study

Persistent self-reported changes in hearing and tinnitus in post-hospitalisation COVID-19 cases

Long-term persistence of olfactory and gustatory disorders in COVID-19 patients

High Prevalence of Headaches During Covid-19 Infection: A Retrospective Cohort Study. Headache

Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)

Health related quality of life of COVID-19 patients after discharge: A multicenter follow up study

Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge

Persistencia de manifestaciones clínicas tras la infección COVID-19: importancia del seguimiento

A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations

Cardiopulmonary recovery after COVID-19 -an observational prospective multi-center trial

Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients' performance: a prospective observational cohort study

Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It? Lung

Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients

Anxiety and depression symptoms after virological clearance of COVID-19: A cross-sectional study in Milan, Italy

Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection

Quantitative evaluation and progress of olfactory dysfunction in COVID-19

Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study

Comprehensive health assessment three months after recovery from acute COVID-19

Post-Discharge Health Status and Symptoms in Patients with Severe COVID-19

Patient-reported outcome measures after COVID-19: a prospective cohort study

Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study

Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery

Laryngeal sensitivity 17%

Bladder control issues 10% * 36 item short-fom survey (SF-36): lower scores indicate higher disability, score of 100 represents the best possible health status. Values presented represent mean (SD). ** mMRC ≥ 2: Walks slower than people of the same age because of dyspnoea or has to stop for breath when walking at own pace *** Patient-Reported Outcomes Measurement Information System 10-Question Short-Form (PROMIS-10 Global Health): Converted normed t-scores, where mean score of 50 and SD of 10 represents the mean for the general US population † weighted average of mild, moderate, and severe baseline COVID-19 patient groups